ARNA FDA play this week 5/10/2012 ARNA Arena Pharmaceutical Inc. Lorcaserin (NDA resubmission) FDA panel to review Lorcaserin for obesity stockcharts.com/c-sc/sc?s=ARNA&p=D&yr=0&mn=6&dy=0&i=p92233808256&a=265591120&r=1336314521730